Leap Therapeutics Inc (LPTX)

01:00 AM

Metastatic Colorectal Cancer Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.

01:00 AM

12:01 PM

Cash-strapped Cambridge cancer biotech halves workforce - The Business Journals

12:01 PM

08:47 AM

Leap Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

08:47 AM

07:46 AM

Leap Therapeutics Q1 Net Income USD -15.435 Million - marketscreener.com

07:46 AM

07:45 AM

Leap Therapeutics Reports First Quarter 2025 Financial Results | - GuruFocus

07:45 AM

07:42 AM

Leap Therapeutics Reports First Quarter 2025 Financial Results - Citizen Tribune

07:42 AM

07:41 AM

Leap TherapeuticsAnnounces 50% Workforce Reduction In Strategic RestructuringSEC Filing - marketscreener.com

07:41 AM

07:02 AM

Leap Therapeutics, Inc. (LPTX) Q1 Loss Beats Estimates - Nasdaq

07:02 AM

06:53 AM

LEAP THERAPEUTICS, INC. SEC 10-Q Report - TradingView

06:53 AM

06:52 AM

Leap Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

06:52 AM

May 12, 2025

Purple Biotech Appoints Shai Lankry as Chief Financial Officer - The Manila Times

May 12, 2025

May 10, 2025

Leap Therapeutics (LPTX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025

May 09, 2025

Leap Therapeutics Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView

May 09, 2025

May 07, 2025

Closing Bell Recap: Leap Therapeutics Inc (LPTX) Ends at 0.34, Reflecting a -12.39 Downturn - DWinneX

May 07, 2025

May 01, 2025

LPTX’s Market Whiplash: -85.46% YTD Decline, 37.04% Rise in 30 Days - investchronicle.com

May 01, 2025

Apr 30, 2025

75,800 Shares in Leap Therapeutics, Inc. (NASDAQ:LPTX) Acquired by LPL Financial LLC - Defense World

Apr 30, 2025

Apr 29, 2025

Quarterly Snapshot: Quick and Current Ratios for Leap Therapeutics Inc (LPTX) - DWinneX

Apr 29, 2025

Apr 25, 2025

Leap Therapeutics to Present Preclinical Data of FL-501, a Novel - GuruFocus

Apr 25, 2025

Apr 25, 2025

Novel Cancer Cachexia Drug FL-501 Shows 3X Better Half-Life in Preclinical Data | LPTX Stock News - Stock Titan

Apr 25, 2025

Apr 23, 2025

Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight - PR Newswire UK

Apr 23, 2025

Apr 15, 2025

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatam - GuruFocus

Apr 15, 2025

Apr 15, 2025

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer | LPTX Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

Leading Oncologist Reveals Game-Changing Phase 2 Results for Advanced Colorectal Cancer Treatment - Stock Titan

Apr 15, 2025

Apr 05, 2025

Leap Therapeutics stock hits 52-week low at $0.28 amid downturn - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

Leap Therapeutics stock hits 52-week low at $0.28 amid downturn By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 03, 2025

BlossomHill Therapeutics to Present the Design and Discovery of BH-30643, the Company’s OMNI-EGFR™ Inhibitor, at the 2025 AACR Annual Meeting - Business Wire

Apr 03, 2025

Mar 31, 2025

HC Wainwright Expects Reduced Earnings for Leap Therapeutics - Defense World

Mar 31, 2025

Mar 29, 2025

Leap Therapeutics (NASDAQ:LPTX) Earns Neutral Rating from HC Wainwright - The AM Reporter

Mar 29, 2025

Mar 29, 2025

HC Wainwright Reiterates Neutral Rating for Leap Therapeutics (NASDAQ:LPTX) - Defense World

Mar 29, 2025

Mar 28, 2025

H.C. Wainwright maintains neutral on Leap Therapeutics stock By Investing.com - Investing.com Canada

Mar 28, 2025

Mar 27, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Mar 27, 2025

Mar 26, 2025

Leap reports progress in colorectal cancer study By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment - Financial Content

Mar 26, 2025

Mar 26, 2025

Micro Cap Soars Following Preliminary Data Update - The Globe and Mail

Mar 26, 2025

Mar 26, 2025

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer - Yahoo

Mar 26, 2025

Mar 26, 2025

LEAP THERAPEUTICS Earnings Results: $LPTX Reports Quarterly Earnings - Nasdaq

Mar 26, 2025

Mar 26, 2025

Leap Therapeutics Says New Data Show Sirexatamab Improves Survival in Colorectal Cancer Trial - MarketScreener

Mar 26, 2025

Mar 26, 2025

Leap Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 26, 2025

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study - MarketScreener

Mar 26, 2025

Mar 26, 2025

Leap Therapeutics Reports Positive DeFianCe Phase 2 Data Of Sirexatamab In Colorectal Cancer - Nasdaq

Mar 26, 2025

Mar 26, 2025

Leap Therapeutics Reports Fourth Quarter And FY 2024 Results - Marketscreener.com

Mar 26, 2025

Mar 26, 2025

Leap reports progress in colorectal cancer study - Investing.com India

Mar 26, 2025

Mar 26, 2025

Breakthrough: Leap's Colorectal Cancer Drug Delivers 32% Higher Response Rate in Latest Trial - Stock Titan

Mar 26, 2025

Mar 26, 2025

Tobacco Control Has Saved Nearly 4 Millions Lives, Study Estimates - 69News WFMZ-TV

Mar 26, 2025

Mar 24, 2025

Leap Therapeutics stock hits 52-week low at $0.39 - Investing.com

Mar 24, 2025

Mar 24, 2025

Leap Therapeutics stock hits 52-week low at $0.39 By Investing.com - Investing.com UK

Mar 24, 2025

Mar 15, 2025

LEAP THERAPEUTICS Earnings Preview: Recent $LPTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025

Mar 11, 2025

Leap Therapeutics stock hits 52-week low at $0.4 amid sharp decline - Investing.com India

Mar 11, 2025

Mar 11, 2025

Leap Therapeutics stock hits 52-week low at $0.4 amid sharp decline By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 11, 2025

Atossa Therapeutics plans to develop durg to treat advanced breast cancer, talks with FDA on other uses - Marketscreener.com

Mar 11, 2025

Mar 10, 2025

Sun Pharma's Strategic Leap: Acquiring Checkpoint Therapeutics - Devdiscourse

Mar 10, 2025

Mar 10, 2025

Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma -March 10, 2025 at 06:24 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Leap Therapeutics (LPTX) to Release Quarterly Earnings on Monday - Defense World

Mar 10, 2025